These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29180558)

  • 1. Using Drug Prescribing Patterns to Identify Stewards of Cost-Conscious Care.
    Gastala NM; Wingrove P; Liaw W; Petterson S; Bazemore A
    J Am Board Fam Med; 2017; 30(6):824-827. PubMed ID: 29180558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):70-76. PubMed ID: 30325706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend analysis of proton pump inhibitor consumption and expenditure: The real-world evidence.
    Ferrara F; Capuozzo M; Celotto V; Ottaiano A; Langella R; Zovi A
    Indian J Gastroenterol; 2024 Jun; 43(3):645-651. PubMed ID: 38231298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Jonasson C; Tvete IF; Hatlebakk JG
    Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
    Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
    BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
    Dhippayom T; Walker R
    Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications.
    McGinn D; Godman B; Lonsdale J; Way R; Wettermark B; Haycox A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):73-85. PubMed ID: 20121565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicaid prescription drug utilization and expenditures following Part D.
    Farley JF; Dusetzina SB
    J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of naproxen/esomeprazole in association for osteoarthrosis treatment in Spain.
    Capel M; Tornero J; Zamorano JL; Oyagüez I; Casado MÁ; Sánchez-Covisa J; Lanas A
    Reumatol Clin; 2014; 10(4):210-7. PubMed ID: 24380809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care.
    Håkansson A; Andersson H; Cars H; Melander A
    Eur J Clin Pharmacol; 2001 Apr; 57(1):65-70. PubMed ID: 11372595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esomeprazole formulary exclusion: impact on total health care services use and costs.
    Alemayehu B; Ke X; Youssef NN; Crawley JA; Levine DS
    Postgrad Med; 2012 May; 124(3):149-63. PubMed ID: 22691909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy.
    Orzella L; Chini F; Giorgi Rossi P; Borgia P
    Health Policy; 2010 May; 95(2-3):236-44. PubMed ID: 20047773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lost generation: flood doors open as large numbers of Canadian FPs head south.
    Korcok M
    CMAJ; 1996 Mar; 154(6):893-6. PubMed ID: 8634968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National health spending in 2006: a year of change for prescription drugs.
    Catlin A; Cowan C; Hartman M; Heffler S;
    Health Aff (Millwood); 2008; 27(1):14-29. PubMed ID: 18180476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.